Live feed16:30:00·22dPRReleaseAlto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline AdvancementsANRO· Alto Neuroscience Inc.Health CareOriginal source
